Development
Tarsus Pharmaceuticals, Inc.
TARS
$41.64
$0.491.19%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.88% | 38.52% | -11.43% | -7.28% | -4.21% |
| Total Receivables | 178.08% | 2,489.43% | -91.57% | -18.54% | -10.72% |
| Inventory | 20,613.33% | -- | -- | -- | -- |
| Prepaid Expenses | 30.98% | 20.09% | 10.93% | -5.41% | 36.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.21% | 41.31% | -12.06% | -7.42% | -3.72% |
|
|
|||||
| Total Current Assets | -1.21% | 41.31% | -12.06% | -7.42% | -3.72% |
| Net Property, Plant & Equipment | -7.64% | -1.44% | 112.23% | 13.12% | -6.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.52% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.31% | -12.07% | 206.39% | -8.18% | 41.54% |
| Total Assets | -1.06% | 42.03% | -10.55% | -7.31% | -3.64% |
|
|
|||||
| Total Accounts Payable | 74.81% | 27.04% | 8.01% | 37.61% | -1.68% |
| Total Accrued Expenses | 56.04% | 40.64% | 23.93% | -46.02% | 13.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.91% | -1.86% | -38.69% | -2.50% | 26.05% |
| Total Finance Division Other Current Liabilities | 28.82% | -- | -- | -- | -- |
| Total Other Current Liabilities | 28.82% | -- | -- | -- | -- |
| Total Current Liabilities | 58.87% | 57.46% | 11.39% | -14.09% | 8.10% |
|
|
|||||
| Total Current Liabilities | 58.87% | 57.46% | 11.39% | -14.09% | 8.10% |
| Long-Term Debt | 0.37% | 20.73% | 0.38% | 26.14% | 0.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.12% | -8.15% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 429.55% | 300.00% | -72.50% | -60.00% | 150.00% |
| Total Liabilities | 25.31% | 32.70% | 8.96% | 8.14% | 3.32% |
|
|
|||||
| Common Stock & APIC | 6.06% | 33.75% | 1.87% | 1.30% | 1.32% |
| Retained Earnings | -20.67% | -23.93% | -23.77% | -21.53% | -14.29% |
| Treasury Stock & Other | 75.00% | 65.22% | 67.14% | 5.41% | -640.00% |
| Total Common Equity | -7.80% | 44.63% | -14.81% | -10.11% | -4.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.80% | 44.63% | -14.81% | -10.11% | -4.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.80% | 44.63% | -14.81% | -10.11% | -4.80% |
|
|
|||||